Literature DB >> 2508732

[A semiquantitative study on Alzheimer neurofibrillary tangles demonstrated immunohistochemically with anti-tau antibodies, in the brains of non-demented and demented old people].

S Kuzuhara1, Y Ihara, Y Toyokura, H Shimada.   

Abstract

Submitted for the study were 116 autopsy brains, from 65 non-demented people, 24 patients with dementia of Alzheimer type (DAT) and 27 patients with vascular dementia, aged between 50 s and 100 s. Formalin-fixed, paraffin-embedded coronal sections of the brains at the level of the lateral geniculate body were immunohistochemically stained with the avidin-biotin-peroxidase complex procedure, using the anti-bodies to tau protein purified from human brains (anti-tau) as the primary antibodies. Alzheimer neurofibrillary tangles (NFTs) which were specifically and selectively stained by anti-tau were semiquantitatively counted in the areas of the hippocampus, parahippocampal gyrus and lateral occipitotemporal gyrus. The results were as follows: 1) In non-demented subjects, NFTs in the hippocampus and parahippocampal gyrus were scanty in the 50 s: they increased markedly after 60 years until 90 as the patients' age increased; they tended to decrease over 90 years. In contrast, NFTs in the lateral occipitotemporal gyrus remained none or scanty, always less than 10/mm2 field, throughout the ages between 50 s and 100 s. 2) In DAT cases, NFTs in the hippocampus and parahippocampal gyrus were numerous in all cases at any ages. NFTs in the lateral occipitotemporal gyrus were also many, and always more than 10/mm2 in all cases except a few ones over 80 years of age. The numbers of NFTs of the three areas were significantly higher in DAT cases than in non-demented subjects. 3) In most cases of vascular dementia, the density and distribution pattern of NFTs were essentially similar to those of non-demented subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508732

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  6 in total

1.  Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy.

Authors:  A Kiuchi; N Otsuka; Y Namba; I Nakano; M Tomonaga
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Katsutoshi Furukawa; Aiko Ishiki; Naoki Tomita; Kotaro Hiraoka; Shoichi Watanuki; Miho Shidahara; Masayasu Miyake; Yoichi Ishikawa; Rin Matsuda; Akie Inami; Takeo Yoshikawa; Tetsuro Tago; Yoshihito Funaki; Ren Iwata; Manabu Tashiro; Kazuhiko Yanai; Hiroyuki Arai; Yukitsuka Kudo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-20       Impact factor: 9.236

Review 3.  Tau protein and neurodegeneration.

Authors:  K S Kosik
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 4.  Characteristics of Tau and Its Ligands in PET Imaging.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Tetsuro Tago; Kazuhiko Yanai; Hiroyuki Arai; Yukitsuka Kudo
Journal:  Biomolecules       Date:  2016-01-06

5.  Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.

Authors:  Aiko Ishiki; Nobuyuki Okamura; Katsutoshi Furukawa; Shozo Furumoto; Ryuichi Harada; Naoki Tomita; Kotaro Hiraoka; Shoichi Watanuki; Yoichi Ishikawa; Tetsuro Tago; Yoshihito Funaki; Ren Iwata; Manabu Tashiro; Kazuhiko Yanai; Yukitsuka Kudo; Hiroyuki Arai
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

Review 6.  Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis.

Authors:  Toshihiko Tashima
Journal:  Pharmaceutics       Date:  2022-02-14       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.